Exeter Automobile Receivables Trust 2023-2 has filed its monthly distribution report for September 2026, revealing no demands for asset repurchase due to breaches of representations and warranties. This filing is significant as it showcases the trust's ongoing stability in the asset-backed securities market, particularly in the auto loan sector.
Exeter Automobile Receivables Trust 2023-2 operates under the Standard Industrial Classification (SIC) code 6189, which pertains to Asset-Backed Securities. The trust is part of a broader industry that includes various financial entities involved in the securitization of assets. The recent filing, dated October 29, 2026, was made under the SEC Act of 1934 and is part of the trust's compliance with ongoing reporting requirements.
The filing states, "No assets securitized by Exeter Finance LLC and held by Exeter Automobile Receivables Trust 2023-2 were the subject of a demand to repurchase for breach of the representations and warranties during the distribution period from September 1, 2026, to September 30, 2026." This indicates that the trust has maintained its asset quality and investor confidence.
This update may have implications for investors and stakeholders in the asset-backed securities market, as it reflects the performance of auto loans within the trust. The absence of repurchase demands suggests a robust performance of the underlying assets, which could enhance investor sentiment in the sector.
Looking ahead, the filing does not specify what actions may follow this report. However, it does indicate that Exeter Finance LLC, the securitizer, has been active in filing necessary documentation, including a recent Form ABS-15G on February 6, 2026. Investors and market participants will likely continue to monitor future filings for further insights into the trust's performance and market conditions.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










